One catch that trips people up: if you have type 2 diabetes, obstructive sleep apnea, or MASH (metabolic liver disease), you cant use the Bridge at all, even if you clear the BMI thresholds above
Instead of targeting hormones or inflammation, it targets your appetite directly
Finally, ask about important safety monitoring: report severe persistent abdominal pain (potential pancreatitis), symptoms of gallbladder disease, visual changes if you have diabetic retinopathy, and signs of dehydration
What gets me really excited is its another option in our toolbox that lands us in double-digit weight loss for individuals struggling with obesity and diabetes, Horn said during a presentation
Ozempic does not directly cause diverticulitis, but it can cause significant constipation